US · Healthcare

Takeda Pharmaceutical Co. Ltd. (TKPHF)

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Co. Ltd. (TKPHF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for TKPHF

P/E ratio

18.00

Takeda Pharmaceutical Co. Ltd. (TKPHF) — FAQ

What is TKPHF's P/E ratio?

The price-to-earnings (P/E) ratio for Takeda Pharmaceutical Co. Ltd. (TKPHF) is 18.00 (data as of 2026-05-23).

Does Takeda Pharmaceutical Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Takeda Pharmaceutical Co. Ltd. (TKPHF). Check the MyAverix Finance app for the latest dividend data.

What sector is Takeda Pharmaceutical Co. Ltd. in?

Takeda Pharmaceutical Co. Ltd. (TKPHF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is TKPHF listed on?

TKPHF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)